Board Meeting31 March 2026 at 05:56 am
Bliss GVS Pharma Ltd Announces Closure of Trading Window Until After Audited Financial Results for FY2026
AI Summary
Bliss GVS Pharma Ltd has announced the closure of the trading window for insiders, designated persons, and their immediate relatives. The closure will take effect from April 01, 2026, until 48 hours after the announcement of the audited financial results for the financial year ending March 31, 2026. The date of the board meeting for the consideration of the audited financial results will be informed later. Insiders, designated persons, and their immediate relatives are advised not to trade in the securities or shares of the company during the aforesaid period.
Key Highlights
- Bliss GVS Pharma Ltd announces closure of trading window for insiders, designated persons, and their immediate relatives.
- The closure will be effective from April 01, 2026, until 48 hours after the announcement of audited financial results for FY2026.
- The date of the board meeting for the consideration of the audited financial results will be informed later.
- Insiders, designated persons, and their immediate relatives are advised not to trade in the securities or shares of the company during the closure period.
- The trading window closure is in accordance with the Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
BLISSGVSPharmaceuticals
BLISS GVS PHARMA LTD.Price Impact